Verbio : 9M/Q3 2025/2026 Quarterly statement

About this update from Verbio Se

‌Quarterly statement for the period ended March 31, 2026 (Q3 2025/2026) Group key figures Segment key figures Business report and the Group's position Consolidated profit and loss account Consolidated balance sheet Consolidated statement of cash flows Financial calendar Group key figures [in EUR millions] Results of operations Q1 2025/2026 Q2 2025/2026 Q3 2025/2026 9M 2025/2026 Revenue 438.2 455.4 447.1 1,340.7 EBITDA 15.4 30.1 60.2 105.7 EBITDA margin (in %) 3.5 6.6 13.5 7.9 EBIT 0.1 14.0 44.2 58.3 Net result for the period - 4.0 3.4 22.9 22.3 Basic earnings per share (EUR) - 0.06 0.05 0.36 0.35 Diluted earnings per share (EUR) - 0.06 0.05 0.36 0.35 Operational statistics Q1 2025/2026 Q2 2025/2026 Q3 2025/2026 9M 2025/2026 Production biodiesel, bioethanol (in tonnes) 320,600 297,423 270,668 888,691 Production biomethane (in MWh) 336,461 337,725 365,932 1,040,118 Utilisation biodiesel, bioethanol (in %) 1) 83.8 78.8 71.7 78.5 Utilisation biomethane (in %) 1) 67.9 68.2 73.9 70.0 Investments in property, plant and equipment 18.7 32.4 14.8 65.9 Number of employees 2) 1,500 1,440 1,394 1,394 Continued on next page 1) For the financial years 2024/2025 and 2025/2026 the annual production capacities of the production plants are as follows: biodiesel: 710,000 tonnes; bioethanol: 800,000 tonnes; biomethane: 1,980 GWh. 2) At the balance sheet date. Group key figures Segment key figures Business report and the Group's position Consolidated profit and loss account Consolidated balance sheet Consolidated statement of cash flows Financial calendar Net asset position 30.09.2025 31.12.2025 31.03.2026 Net debt 203.8 173.6 126.8 Equity 743.2 742.8 768.8 Equity ratio (in %) 57.9 58.2 59.3 Balance sheet total 1,283.4 1,276.0 1,296.1 Financial position Q1 2025/2026 Q2 2025/2026 Q3 2025/2026 9M 2025/2026 Operating cash flow - 17.3 52.9 60.8 96.4 Operating cash flow per share (EUR) - 0.27 0.83 0.95 1.51 Cash and cash equivalents 1) 65.0 86.4 68.7 68.7 1) At the balance sheet date; includes amounts held in segregated accounts. Group key figures Segment key figures Business report and the Group's position Consolidated profit and loss account Consolidated balance sheet Consolidated statement of cash flows Financial calendar Group key figures [in EUR millions] Results of operations Q1 2024/2025 Q2 2024/2025 Q3 2024/2025 9M 2024/2025 Revenue 358.0 393.6 394.9 1,146.5 EBITDA - 6.6 20.8 8.2 22.4 EBITDA margin (in %) - 1.8 5.3 2.1 2.0 EBIT - 21.5 5.6 - 8.3 - 24.2 Net result for the period - 22.9 - 3.5 - 14.1 - 40.5 Basic earnings per share (EUR) - 0.36 - 0.06 - 0.22 - 0.64 Diluted earnings per share (EUR) - 0.36 - 0.05 - 0.22 - 0.64 Operational statistics Q1 2024/2025 Q2 2024/2025 Q3 2024/2025 9M 2024/2025 Production biodiesel, bioethanol (in tonnes) 301,862 298,563 278,693 879,118 Production biomethane (in MWh) 271,203 288,482 305,649 865,334 Utilisation biodiesel, bioethanol (in %) 1) 80.0 79.1 73.8 77.6 Utilisation biomethane (in %) 1) 54.8 58.3 61.7 58.3 Investments in property, plant and equipment 25.9 36.0 29.6 91.5 Number of employees 2) 1,540 1,521 1,491 1,491 Continued on next page 1) For the financial years 2024/2025 and 2025/2026 the annual production capacities of the production plants are as follows: biodiesel: 710,000 tonnes; bioethanol: 800,000 tonnes; biomethane: 1,980 GWh. 2) At the balance sheet date. Group key figures Segment key figures Business report and the Group's position Consolidated profit and loss account Consolidated balance sheet Consolidated statement of cash flows Financial calendar Net asset position 30.09.2024 31.12.2024 31.03.2025 Net debt 63.1 97.0 154.1 Equity 884.9 903.9 874.6 Equity ratio (in %) 65.0 64.7 63.1 Balance sheet total 1,361.7 1,397.9 1,386.9 Financial position Q1 2024/2025 Q2 2024/2025 Q3 2024/2025 9M 2024/2025 Operating cash flow - 6.1 12.3 - 17.7 - 11.5 Operating cash flow per share (EUR) - 0.10 0.20 - 0.29 - 0.18 Cash and cash equivalents 1) 121.3 100.5 78.5 78.5 1) At the balance sheet date; includes amounts held in segregated accounts. Group key figures Segment key figures Business report and the Group's position Consolidated profit and loss account Consolidated balance sheet Consolidated statement of cash flows Financial calendar Segment key figures [in EUR millions] Biodiesel Q1 2025/2026 Q2 2025/2026 Q3 2025/2026 9M 2025/2026 Revenue 244.1 223.8 202.7 670.6 EBITDA 22.6 24.1 18.5 65.2 EBIT 19.4 20.8 15.2 55.5 Production (in tonnes) 166,885 144,292 146,520 457,696 Utilisation (in %) 1) 94.0 81.3 82.5 86.0 Number of employees 2) 255 257 267 267 Bioethanol/Biomethane Q1 2025/2026 Q2 2025/2026 Q3 2025/2026 9M 2025/2026 Revenue 191.2 228.0 236.3 655.5 EBITDA - 9.5 5.8 34.2 30.5 EBIT - 20.3 - 5.9 22.8 - 3.4 Production bioethanol (in tonnes) 153,714 153,131 124,149 430,995 Production biomethane (in MWh) 336,461 337,725 365,932 1,040,118 Utilisation bioethanol (in %) 1) 76.9 76.6 62.1 71.8 Utilisation biomethane (in %) 1) 67.9 68.2 73.9 70.0 Number of employees 2) 740 676 627 627 Other Q1 2025/2026 Q2 2025/2026 Q3 2025/2026 9M 2025/2026 Revenue 8.2 7.2 12.3 27.8 EBITDA 2.3 0.2 7.6 10.0 Group key figures Segment key figures Business report and the Group's position Consolidated profit and loss account Consolidated balance sheet Consolidated statement of cash flows Financial calendar Segment key figures [in EUR millions] Biodiesel Q1 2024/2025 Q2 2024/2025 Q3 2024/2025 9M 2024/2025 Revenue 197.1 242.5 210.3 649.8 EBITDA 15.4 36.6 16.8 68.8 EBIT 12.5 33.7 14.0 60.2 Production (in tonnes) 161,833 164,245 133,026 459,104 Utilisation (in %) 1) 91.2 92.5 74.9 86.2 Number of employees 2) 248 250 257 257 Bioethanol/Biomethane Q1 2024/2025 Q2 2024/2025 Q3 2024/2025 9M 2024/2025 Revenue 157.5 146.9 181.5 486.0 EBITDA - 21.5 - 15.3 - 14.0 - 50.9 EBIT - 32.4 - 26.4 - 26.6 - 85.4 Production bioethanol (in tonnes) 140,029 134,318 145,667 420,015 Production biomethane (in MWh) 271,203 288,482 305,649 865,334 Utilisation bioethanol (in %) 1) 70.0 67.2 72.8 70.0 Utilisation biomethane (in %) 1) 54.8 58.3 61.7 58.3 Number of employees 2) 765 723 697 697 Other Q1 2024/2025 Q2 2024/2025 Q3 2024/2025 9M 2024/2025 Revenue 9.3 9.0 8.8 27.1 EBITDA - 0.4 - 0.4 5.4 4.5 Group key figures Segment key figures Business report and the Group's position Consolidated profit and loss account Consolidated balance sheet Consolidated statement of cash flows Financial calendar Business report and the Group's position The production volume of biodiesel and bioethanol in the period from July 1, 2025 to March 31, 2026 totalled 888,691 tonnes, compared with 879,118 tonnes in the same period in the previous year. The increase in production volumes is due to the ongoing ramp-up in Nevada. In addition, 1,040 GWh of biomethane were produced in the first nine months of the financial year 2025/2026 (9M 2024/2025: 865 GWh). As a result, Verbio once again exceeded the previous year's production volumes for both biomethane and bioethanol, setting new production records. Results of operations Group revenues increased by 17 percent to EUR 1,340.7 million in the first nine months of the financial year compared to the same period in the previous year (9M 2024/2025: EUR 1,146.5 million). In particular, a key factor in this was the rising demand for GHG quotas in an increasingly stabilised market environment, which was reflected in both rising trading volumes and higher selling prices. Earnings before interest, taxes and depreciation and amortisation (EBITDA) for the first nine months of the financial year were EUR 105.7 million (9M 2024/2025: EUR 22.4 million). The increase in EBITDA is primarily attributable to a EUR 64.8 million improvement in the gross margin and to cost reductions. This was supported by the development of other operating income and the effects of commodity forward contracts. This development was primarily driven by the Bioethanol/Biomethane segment, which saw a significant recovery in the GHG quota market. The Group result before taxes and interest (EBIT) totalled EUR 58.3 million (9M 2024/2025: EUR - 24.2 million). The net result for the period amounted to EUR 22.3 million (9M 2024/2025: EUR - 40.5 million). Based on the result for the period, basic earnings per share were EUR 0.35 (9M 2024/2025: EUR - 0.64). Group revenues in the third quarter totalled EUR 447.1 million (Q3 2024/2025: EUR 394.9 million), 13 percent above the previous year's level. EBITDA increased by EUR 52.0 million and amounted to EUR 60.2 million (Q3 2024/2025: EUR 8.2 million). In particular, the ongoing market recovery, combined with the seasonally high demand for GHG quotas as well as increased biomethane sales volumes, was reflected in the very positive development of the quarterly results. Further information is presented in the detailed comments on the individual segments. Net assets and financial position Assets and liabilities The balance sheet total at March 31, 2026 amounted to EUR 1,296.1 million, representing an increase of EUR 13.0 million compared to June 30, 2025 (EUR 1,283.1 million). On the assets side of the balance sheet, the major change of note was the increase in non-current assets. The increase in non-current assets (EUR 755.3 million; June 30, 2025: EUR 724.0 million) primarily resulted from investments in property, plant and equipment, which continued to exceed scheduled depreciation charges. Offsetting this is a decrease in current assets compared to June 30, 2025 of EUR 18.3 million, falling from EUR 559.1 million to EUR 540.8 million, primarily due to the lower level of inventories (EUR 258.2 million; June 30, 2025: EUR 275.7 million) and cash and cash equivalents (EUR 54.9 million; June 30, 2025: EUR 64.4 million), lower current tax receivables (EUR 2.3 million, June 30, 2025: EUR 14.0 million) and lower current financial assets (EUR 21.9 million, June 30, 2025: EUR 34.0 million). The decrease in inventories is explained in particular by the seasonal sale of GHG quotas generated in the calendar year 2025 for the obligation year 2025. This is offset by an increase in the value of derivative assets (EUR 63.6 million; June 30, 2025: EUR 32.0 million). Group key figures Segment key figures Business report and the Group's position Consolidated profit and loss account Consolidated balance sheet Consolidated statement of cash flows Financial calendar The equity and liabilities side of the balance sheet includes equity of EUR 768.8 million (June 30, 2025: EUR 746.3 million), representing approximately 59.3 percent (June 30, 2025: 58.2 percent) of the balance sheet total. Non-current liabilities increased compared to the June 30, 2025 year end (March 31, 2026: EUR 244.6 million; June 30, 2025: EUR 228.4 million) as a result of additional investment subsidies. Within current liabilities there has been a decrease compared to June 30, 2025 in particular in loans (March 31, 2026: EUR 19.6 million; June 30, 2025: EUR 65.4 million) and other current financial liabilities (EUR 29.9 million, June 30, 2025: EUR 46.6 million). This is offset by an increase in the value of liabilities for derivatives (March 31, 2026: EUR 66.3 million; June 30, 2025: EUR 31.8 million). As a result there has been an overall decrease in current liabilities compared to the June 30, 2025 year end, from EUR 308.4 million to EUR 282.8 million. Cash flows The cash flow from operating activities in the first nine months of the financial year 2025/2026 was significantly higher than in the previous year, amounting to EUR 96.4 million (9M 2024/2025: EUR - 11.5 million). The increase compared to the previous year is primarily attributable, in addition to the higher result for the period, to a reduction in inventories amounting to EUR 17.5 million (9M 2024/2025: an increase in inventories of EUR 45.5 million), which had a cash-generating effect. By contrast, the reduction in other current financial and non-financial liabilities was significantly smaller (9M 2025/2026: EUR 27.2 million; 9M 2024/2025: EUR 10.7 million). Driven by investment activities in the first nine months of 2025/2026, the Group reports total cash outflows of EUR 53.1 million (9M 2024/2025: EUR 84.3 million). In the current financial year, the investments primarily reflect payments made for investments in property, plant and equipment (EUR 63.4 million; 9M 2024/2025: EUR 96.3 million), whereby a slowdown in investment activities has been recorded. Free cash flow (operating cash flow less investments in property, plant and equipment) thus amounted to EUR 33.0 million (9M 2024/2025: EUR - 107.8 million). The cash flow from financing activities totalled EUR - 53.0 million (9M 2024/2025: EUR 45.5 million). Net cash outflows for the repayment of financial liabilities in the current financial year totalled EUR 45.1 million (9M 2024/2025: net cash inflows for drawdowns of EUR 66.5 million). In both periods cash outflows also include payments for the redemption of lease liabilities (9M 2025/2026: EUR 8.0 million; 9M 2024/2025: EUR 8.2 million). In the previous year further cash outflows of EUR 12.7 million resulted from the payment of the dividend for the financial year 2023/2024. As a result of the above, cash funds decreased by a total of EUR 9.8 million in the period from July 1, 2025 to March 31, 2026. Liquid funds reported in the balance sheet at March 31, 2026 amounted to EUR 54.9 million. Net debt The Group's bank and loan financing arrangements totalling EUR 195.5 million are offset by liquid funds and cash held in segregated accounts totalling EUR 68.7 million, so that the reported net debt at March 31, 2026 amounted to EUR 126.8 million (June 30, 2025: EUR 164.0 million). Development of the Biodiesel, Bioethanol/Biomethane and Other segments In the Biodiesel segment, production in Europe reached a new record high in the third quarter of 2025/2026, resulting in an increase in total production compared with the third quarter of 2024/2025. Due to changes in the regulatory framework conditions in North America, volumes in Canada were kept at a low level in line with plan during the reporting period. Due to a slight decrease in sales volumes, revenue decreased slightly in the third quarter from EUR 210.3 million to EUR 202.7 million. However, taking into account the change in inventories of work in progress and finished goods, as well as a slight decrease in material costs, the gross margin nevertheless increased. As a result Verbio could increase EBITDA in the segment, reaching EUR 18.5 million compared with EUR 16.8 million in the third quarter of 2024/2025. In the Bioethanol/Biomethane segment, Verbio set a new production record for biomethane in the third quarter of 2025/2026 following the ramp-up of the plant in Nevada. Bioethanol production volumes decreased compared to the same quarter of the previous year, primarily due to a temporary biological disruption to the fermentation processes in Europe. Revenue increased to EUR 236.3 million in Q3 2025/2026 from EUR 181.5 million in Q3 2024/2025. The significant drivers were the recovery of the GHG quota market and strong seasonal demand for GHG quotas, as well as higher sales volumes of biomethane. Group key figures Segment key figures Business report and the Group's position Consolidated profit and loss account Consolidated balance sheet Consolidated statement of cash flows Financial calendar The increase in EBITDA of EUR 48.2 million compared to the same quarter of the previous year was primarily due to the contribution to earnings from the GHG quota business, resulting in total EBITDA of EUR 34.2 million in the third quarter (EBITDA Q3 2024/2025: EUR - 14.0 million). Lower grain purchase prices resulted in a significant reduction in the cost of materials and had a positive effect on margins. In the Other segment, Verbio generated revenues of EUR 12.3 million in the third quarter of 2025/2026 (Q3 2024/2025: EUR 8.8 million) from transport and logistics services. Together with the expenses and income from the Trading division, the reported segment EBITDA was EUR 7.6 million (Q3 2024/2025: EUR 5.4 million). Profit from commodity forward contracts in the segment amounted to EUR 11.3 million; the majority of this has been realised. Outlook, opportunity and risk report Forecast report On the publication of the annual report 2024/2025 on September 25, 2025, the Management Board forecast EBITDA in the high double-digit millions for the financial year 2025/2026, and on this basis expected a moderate reduction in net financial debt. An upward correction of this forecast was communicated in an ad hoc announcement on March 25, 2026. Based on the business performance to date as well as current sales and raw material price levels, EBITDA was now expected to be between EUR 100 million and EUR 140 million. The forecast was formulated with a wide range, as the geopolitical environment remains dynamic. Given the ongoing high selling prices, supported by a favourable regulatory environment and geopolitical factors, Verbio is revising its EBITDA forecast for the full year 2025/2026 to the upper end of the forecast range. The expectations for net financial debt at the end of the financial year were revised downwards in the ad hoc announcement on March 25, 2026, and was now projected to be in the region of EUR 140 million. Following the firming-up of its EBITDA expectations, the Management Board now expects net financial debt to be less than EUR 140 million at the end of the financial year. Risk and opportunity report Detailed information on Verbio's risk management system, and on the Group's opportunities and risks, is presented in the risk and opportunity report included in the 2024/2025 annual report. There were no significant changes in the assessment of risks and opportunities in the reporting period. At the current time there are no identifiable risks that could threaten the ability of Verbio and its subsidiaries to continue as a going concern. The third quarter of our financial year was marked by increased geopolitical uncertainty. The military conflict between Iran, Israel, the US and other parties in the Middle East, which has been ongoing since the end of February 2026, continues to cause significant tension in the region. This has led to significant price rises in almost all markets. In principle, this creates a risk - or an opportunity - of a disparity between the prices of raw materials and the prices of finished products, in this case particularly biodiesel and bioethanol. There is also a risk that the significant increases in energy costs in production cannot be passed on in the prices of final products. Supplies to our production locations are currently secure. Nevertheless, we are monitoring market developments closely and adapting both our procurement and sales strategies as the situation requires. The vulnerability of global supply chains, which has recently become apparent once again, highlights the strengths of bioenergy - and BioLNG in particular - in the German transport sector, whereby price stability and security of supply help to drive structural demand for our products. Significant events after March 31, 2026 On May 8, the implementation of the revised Renewable Energy Directive (RED III) was passed by the upper house of the German parliament. This resolution addresses the systemic misguided incentives that have led to significant market distortions in the biofuels market in recent years, as well as to a loss of confidence in the GHG quota system. The abolition of double counting of advanced biofuels towards the GHG quota had already been considered largely certain since January 1, 2026 and was consequently reflected in market behaviour and, accordingly, in Verbio's financial reporting. These assumptions have now been confirmed by the resolution. Group key figures Segment key figures Business report and the Group's position Consolidated profit and loss account Consolidated balance sheet Consolidated statement of cash flows Financial calendar Consolidated profit and loss account for the period from July 1, 2025 to March 31, 2026 EUR (thousands) Q3 2025/2026 Q3 2024/2025 9M 2025/2026 9M 2024/2025 1. Revenue 447,075 394,874 1,340,730 1,146,459 2. Changes in inventories of finished goods and work in progress - 34,261 423 - 38,351 29,904 3. Own work capitalised 1,380 1,655 3,946 4,327 4. Other operating income 4,261 3,300 13,471 9,540 5. Raw material and consumables used - 313,253 - 342,749 - 1,068,333 - 1,007,127 6. Employee benefit expense - 26,385 - 26,596 - 78,344 - 79,496 7. Other operating expenses - 27,551 - 32,076 - 85,844 - 92,765 8. Changes in the value of financial assets and liabilities 493 - 1,134 940 - 641 9. Result from commodity forward contracts 8,474 10,478 17,517 12,243 10. EBITDA 60,233 8,174 105,733 22,444 11. Depreciation and amortisation - 15,997 - 16,503 - 47,402 - 46,687 12. Operating result (EBIT) 44,236 - 8,329 58,331 - 24,243 13. Finance income 1,068 158 2,273 756 14. Finance costs - 2,215 - 2,715 - 6,959 - 7,174 15. Finance result - 1,148 - 2,558 - 4,686 - 6,418 16. Result before tax 43,088 - 10,886 53,645 - 30,661 17. Income tax expense - 20,142 - 3,186 - 31,360 - 9,811 18. Net result for the period 22,947 - 14,072 22,284 - 40,472 Result attributable to shareholders of the parent company 22,947 - 14,138 22,284 - 40,629 Basic earnings per share (EUR) 0.36 - 0.22 0.35 - 0.64 Diluted earnings per share (EUR) 0.36 - 0.22 0.35 - 0.64 Group key figures Segment key figures Business report and the Group's position Consolidated profit and loss account Consolidated balance sheet Consolidated statement of cash flows Financial calendar Consolidated balance sheet at March 31, 2026 EUR (thousands) 31.03.2026 30.06.2025 Assets A. Non-current assets I. Intangible assets 1,356 1,533 II. Property, plant and equipment 718,327 690,144 III. Right-of-use assets under leasing arrangements 30,805 28,948 IV. Financial assets 1,160 1,160 V. Other non-current assets 742 743 VI. Deferred tax assets 2,892 1,472 Total non-current assets 755,281 724,000 B. Current assets I. Inventories 258,230 275,720 II. Trade receivables 109,736 108,950 III. Derivatives 63,554 31,970 IV. Other current financial assets 21,882 33,971 V. Current tax receivables 2,271 13,974 VI. Other current assets 30,303 30,080 VII. Cash and cash equivalents 54,867 64,405 Total current assets 540,844 559,070 Total assets 1,296,125 1,283,070 Continued on next page Group key figures Segment key figures Business report and the Group's position Consolidated profit and loss account Consolidated balance sheet Consolidated statement of cash flows Financial calendar EUR (thousands) 31.03.2026 30.06.2025 Equity and liabilities A. Equity I. Share capital 63,716 63,716 II. Capital reserve 509,328 507,485 III. Retained earnings 219,964 197,679 IV. Reserve for cash flow hedges - 4,292 1,963 V. Translation reserve - 19,934 - 24,554 Equity attributable to owners of the parent 768,782 746,289 VI. Non-controlling interests 0 0 Total equity 768,782 746,289 B. Non-current liabilities I. Borrowings 175,941 173,413 II. Lease liabilities 23,072 21,213 III. Non-current provisions 2,217 2,052 IV. Investment grants 39,693 28,570 V. Other non-current financial liabilities 33 33 VI. Deferred tax liabilities 3,599 3,087 Total non-current liabilities 244,556 228,368 Continued on next page Group key figures Segment key figures Business report and the Group's position Consolidated profit and loss account Consolidated balance sheet Consolidated statement of cash flows Financial calendar EUR (thousands) 31.03.2026 30.06.2025 C. Current liabilities I. Borrowings 19,568 65,364 II. Lease liabilities 8,991 8,868 III. Trade payables 123,746 127,882 IV. Derivatives 66,307 31,799 V. Other current financial liabilities 29,985 46,558 VI. Current tax payable 24,389 1,198 VII. Current provisions 1,918 6,092 VIII. Investment grants 2,214 2,175 IX. Other current liabilities 5,669 18,477 Total current liabilities 282,787 308,413 Total equity and liabilities 1,296,125 1,283,070 Group key figures Segment key figures Business report and the Group's position Consolidated profit and loss account Consolidated balance sheet Consolidated state ment of cash flows Financial calendar Consolidated statement of cash flows for the period from July 1, 2025 to March 31, 2026 EUR (thousands) 9M 2025/2026 9M 2024/2025 Net result for the period 22,284 - 40,472 Income tax expense 31,360 9,811 Finance result 4,686 6,418 Depreciation, amortisation and impairment of non-current assets 47,402 46,687 Non-cash expenses for share-based remuneration 1,811 1,157 Other non-cash income and expenses 2,071 - 430 Gain on disposal of property, plant and equipment 15 149 Release of investment grants - 1,673 - 1,839 Non-cash changes in derivative financial instruments - 2,662 362 Decrease (previous year: increase) in inventories 17,490 - 45,548 Increase (previous year: decrease) in trade receivables - 786 3,925 Decrease in other assets and other current financial assets 12,257 11,824 Decrease (previous year: increase) in provisions - 4,031 956 Decrease (previous year: increase) in trade payables - 2,342 7,846 Decrease in other current financial and non-financial liabilities - 27,207 - 10,680 Interest paid - 6,066 - 5,716 Interest received 268 756 Income taxes received 1,520 3,291 Cash flows from operating activities 96,399 - 11,502 Continued on next page Group key figures Segment key figures Business report and the Group's position Consolidated profit and loss account Consolidated balance sheet Consolidated state ment of cash flows Financial calendar EUR (thousands) 9M 2025/2026 9M 2024/2025 Acquisition of intangible assets - 395 - 703 Acquisition of property, plant and equipment - 63,420 - 96,282 Proceeds from sale of property, plant and equipment 553 1,150 Proceeds from investment grants 12,163 11,491 Acquisition of shareholdings in subsidiary companies - 2,050 0 Cash flows from investing activities - 53,149 - 84,345 Dividends paid 0 - 12,728 Repayment of borrowings - 153,291 - 90,500 Proceeds from borrowings 108,212 156,975 Repayment of lease liabilities - 7,952 - 8,242 Cash flows from financing activities - 53,031 45,505 Net change in cash funds - 9,781 - 50,342 Effects of exchange rate changes on cash funds 243 - 161 Cash funds at the beginning of the period 64,405 123,186 Cash funds at the end of the period 54,867 72,683 Group key figures Segment key figures Business report and the Group's position Consolidated profit and loss account Consolidated balance sheet Consolidated statement of cash flows Financial calendar Financial calendar September 24, 2026 Annual report 2025/2026 for the year ended June 30, 2026 (FY 2025/2026) Financial statement press and analysts' conference November 12, 2026 Quarterly statement for the period ended September 30, 2026 (Q1 2026/2027) December 4, 2026 Annual general meeting of Verbio SE (to be held virtually) February 11, 2027 Half-year financial report for the period ended December 31, 2026 (H1/Q2 2026/2027) May 13, 2027 Quarterly statement for the period ended March 31, 2027 (9M/Q3 2026/2027) September 23, 2027 Annual report 2026/2027 for the year ended June 30, 2027 (FY 2026/2027) Financial statement press and analysts' conference Forward-looking statements This quarterly statement includes various statements concerning forecasts, expectations and information that relate to the future development of the Verbio Group and Verbio SE. These statements are based on current assumptions and estimates and may be associated with known and unknown risks, uncertainties and contingencies. Actual developments and results, as well as the financial and asset position, may therefore differ significantly from the expressed expectations and assumptions. Such differences may be due, among other things, to market fluctuations, changes in worldwide market prices for raw materials as well as financial markets and exchange rates, changes in national and international laws and regulations, fundamental changes in the economic and political climate, geopolitical conflicts, pandemics, tariffs and embargoes, changes in interest rates or changes in the Company's corporate strategy. Verbio does not intend to and does not undertake an obligation to update, revise or adjust any forward-looking statements to adapt them to events or developments after the publication of this quarterly statement. This quarterly statement is published in German (original version) and in English (non-binding translation). It is available for download in both languages on the internet at https://www.verbio.de . Further information about Verbio SE is available on request. Telephone: +49 341 308530-0 Email: [email protected] Imprint Publisher/editor Verbio SE Contact Verbio SE Ritterstraße 23 (Oelßner's Hof) 04109 Leipzig Telephone: +49 341 308530-0 https://www.verbio.de

View stock analysis, news, and events for Verbio Se